Triumph Awarded Door Actuation Contract From Airbus

Triumph Group, Inc. (TRIUMPH) (NYSE:TGI) announced that its Actuation Products and Services business has been awarded a contract from Airbus to provide A220 On Wing Emergency Exit Door (OWEED) control cables. The

byBenzinga Newsdesk

January 25, 2023

1 minute read

Morgan Stanley Maintains Overweight on Telephone and Data, Lowers Price Target to $33.5

By Benzinga Newsdesk

Today, 1:15 PM

Morgan Stanley maintains Telephone and Data (NYSE:TDS) with a Overweight and lowers the price target from $38.5 to $33.5.

TDS

News
Tech

Tesla Ranks 2nd For Best In-Vehicle Tech Among Mass-Market NEVs In China — This EV Maker Stood First In JD Power Study

By Rachit Vats

Today, 1:15 PM

U.S.-listed upcoming Chinese electric vehicle maker Xpeng Inc (NYSE: XPEV) has emerged as the top mass-market new energy vehicle brand in China to adopt technology, as per J.D.

BMWYY

Sio Gene Therapies Announces Dosing Of First GM1 Gangliosidosis Early Infantile Patient In Ongoing Phase 1/2 Study Of AXO-AAV-GM1 Gene Therapy

By Benzinga Newsdesk

Today, 1:15 PM

Sio Gene Therapies Inc. (NASDAQ:SIOX), a clinical-stage company focused on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases, today announced dosing of the first Type

SIOX

EXCLUSIVE: How You Can Own A Piece Of A Warren Buffett Autograph, An Increasingly Rare Asset

By Chris Katje

Today, 1:15 PM

Ever wanted to own an autograph from the Oracle of Omaha Warren Buffett? While you may not be able to afford your own autograph to display at your home, you can buy shares of an autograph from the legendary investor thanks to an alternative investment platform.

AAPL

Triumph Awarded Door Actuation Contract From Airbus

Related Posts

Morgan Stanley Maintains Overweight on Telephone and Data, Lowers Price Target to $33.5

Tesla Ranks 2nd For Best In-Vehicle Tech Among Mass-Market NEVs In China — This EV Maker Stood First In JD Power Study

Sio Gene Therapies Announces Dosing Of First GM1 Gangliosidosis Early Infantile Patient In Ongoing Phase 1/2 Study Of AXO-AAV-GM1 Gene Therapy

EXCLUSIVE: How You Can Own A Piece Of A Warren Buffett Autograph, An Increasingly Rare Asset